Diabeloop Unveils New DBLG2 Demo App: Experience the Future of Automated Insulin Delivery Simulation
GRENOBLE, France - July 1, 2026 - Diabeloop, a pioneer in therapeutic AI, today announced the launch of a new, highly ...
The t:slim X2™ insulin pump from Tandem Diabetes Care is now compatible with Abbott’s FreeStyle Libre 3 Plus CGM sensor in ...
Zacks Investment Research on MSN
If you invested $1000 in Insulet 10 years ago, this is how much you'd have now
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and ...
Zacks Investment Research on MSN
MiniMed launches Abbott's Instinct sensors across European markets
MiniMed MMED recently announced the commercial launch of its MiniMed 780G automated insulin delivery system integrated with Abbott Laboratories' ABT Instinct sensor and the MiniMed Go system ...
NORTHRIDGE, Calif. – MiniMed has announced its first commercial launch of the MiniMed Flex system in the United States – the company’s first app-controlled pump and its smallest insulin pump yet. The ...
Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type 1 and type 2 ...
Insulet has begun shipping Omnipod 5 pods with the new algorithm to US retailers ahead of a broader software update.
A new study led by Marc D. Breton, Ph.D., found that a University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage ...
Over the past two decades, the management of diabetes has undergone a profound transformation driven by rapid technological innovation (1, 2). Advances in continuous glucose monitoring (CGM), ...
A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...
For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug before it could work—forcing millions of patients to rely on daily injections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results